Literature DB >> 9165633

Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model.

D M Ziedonis1, K Trudeau.   

Abstract

Although the motivation to quit using substances is an important prognostic and treatment-matching factor in substance abuse treatment, there is limited information on motivation to quit among individuals with schizophrenia. This study used the five-stages-of-change model to evaluate the motivational levels of 497 individuals with schizophrenia or schizoaffective disorder in an outpatient mental health clinic. Rates of substance abuse, motivation levels to quit each specific substance, and correlates to motivational levels were evaluated. At least one substance use disorder was diagnosed in 224 of the subjects (45%); however, there was significant variability among the caseloads of the outpatient division teams. The patients in the triage/acute services and community outreach teams had substance abuse rates of about 70 percent. Most subjects had low motivation to quit substances, and the rates varied according to substance (range of 41% for opiates to 60% for cocaine). Treatment-matching strategies are suggested in the motivation-based treatment model.

Entities:  

Mesh:

Year:  1997        PMID: 9165633     DOI: 10.1093/schbul/23.2.229

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  25 in total

Review 1.  Managing comorbid schizophrenia and substance abuse.

Authors:  R E Drake; K T Mueser
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

2.  Long-term sobriety strategies for men with co-occurring disorders.

Authors:  Alison Luciano; Elisabeth L Bryan; Elizabeth A Carpenter-Song; Mary Woods; Katherine Armstrong; Robert E Drake
Journal:  J Dual Diagn       Date:  2014

3.  Measuring readiness-to-change substance misuse among psychiatric outpatients: I. Reliability and validity of self-report measures.

Authors:  K B Carey; S A Maisto; M P Carey; D M Purnine
Journal:  J Stud Alcohol       Date:  2001-01

4.  Use of the Transtheoretical Model for individuals with co-occurring disorders.

Authors:  Deborah S Finnell
Journal:  Community Ment Health J       Date:  2003-02

Review 5.  Behavioral therapies for co-occurring substance use and mood disorders.

Authors:  Kathleen M Carroll
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

6.  Concurrent substance-related disorders and mental illness: the North American experience.

Authors:  Nady el-Guebaly
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

7.  Decisional balance regarding substance use among persons with schizophrenia.

Authors:  K B Carey; D M Purnine; S A Maisto; M P Carey; K L Barnes
Journal:  Community Ment Health J       Date:  1999-08

8.  [State-dependent motivational interviewing for people with schizophrenia and substance use: results of a randomised controlled trial].

Authors:  A Bechdolf; B Pohlmann; J Güttgemanns; C Geyer; K Lindner; C Ferber; E Gouzoulis-Mayfrank
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

9.  Predictors of smoking cessation group treatment engagement among veterans with serious mental illness.

Authors:  Letitia E Travaglini; Lan Li; Clayton H Brown; Melanie E Bennett
Journal:  Addict Behav       Date:  2017-07-10       Impact factor: 3.913

10.  Substance dependence: Decades apart in a teaching hospital.

Authors:  J Venkatesan; Stelina S D Suresh
Journal:  Indian J Psychiatry       Date:  2008-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.